Läkemedelsverket I USA (FDA) kräver varningsmärkning av statiner.
Man varnar för leverskador, minnesförlust och förvirring, typ-2 diabetes och muskelsvaghet
· The
U.S. Food and Drug Administration (FDA) is requiring additional warning
labels for the cholesterol-lowering drug class known as statins,
warning that the drugs may increase your risk of liver damage, memory
loss and confusion, type 2 diabetes and muscle weakness
· The
FDA has removed a long-standing warning advising routine monitoring of
liver enzymes in people taking statins, even though the drugs are linked
to serious liver damage
· One
in four Americans aged 45 and older take statin drugs to lower
cholesterol, and many are unaware of the serious risks associated with
the drugs
· The majority of people taking statin drugs do not need them, and in fact are risking their health unnecessarily by doing so
· Over 60,000 people EVERY year in the US will develop diabetes solely as a result of taking statin drugs
Inga kommentarer:
Skicka en kommentar